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The finding of a role for nucleoplasmic 
Nups in transcription provides an impor-
tant advance in our knowledge of the 
basic role of nucleoporins in gene regula-
tion. Contrary to their proposed function in 
the “gene-gating” model, nucleoplasmic 
Nups directly participate in the activation 
of transcription away from the NPCs on the 
nuclear envelope. Some Nups are highly 
dynamic and rapidly shuttle between 
NPCs and the nucleoplasm. If these Nups 
are involved in both transcription inside the 
nucleoplasm and trafficking at the NPCs, 
it would be tempting to speculate that 
they may bridge two fundamental cellular 
processes taking place in the inside of the 
nucleus and at the periphery. This finding 
challenges the conventional views of how 
the constituents of NPCs regulate gene 
expression at the nuclear periphery and 
also potentially excludes the necessity of 
bringing chromatin to the NPCs in order to 
affect transcription.
Half a century after first unveiling the 
existence of the NPCs (Watson, 1959), 
the work of Capelson et al. and Kalverda 
et al. places a new cornerstone in nuclear 
biology upon which to build a better 
understanding of the role of nuclear 
transport components in transcription 
regulation. Like all key discoveries, these 
studies raise many additional questions. 
Most of the Nups lack structural motifs 
suggestive of a DNA-binding function. 
Therefore, it will be of interest to eluci-
date how nucleoplasmic Nups associate 
with chromatin and how they selectively 
bind to distinct subsets of genes involved 
in different biological processes. Due to 
the strict requirement of NPCs for direc-
tional transport between the cytoplasm 
and the nucleoplasm, it will be important 
to understand whether this additional 
function of the Nups will affect NPC 
activity under physiological conditions 
that require active transport of proteins 
and mRNAs. Elucidation of the molecu-
lar mechanisms by which the Nups par-
ticipate in gene regulation may give new 
insights into the interplay among differ-
ent nuclear compartments in the activa-
tion of eukaryotic genes.
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The tumor suppressor protein p53, a crucial player in the DNA damage response, is regulated 
in many ways, most notably through ubiquitination. In this issue, Yuan et al. (2010) identify the 
deubiquitinating protease USP10 as a new regulator of p53 in the DNA damage response and 
tumor development.Many oncogenic alterations in cellular 
genomes may never result in tumors: 
rather than boosting cell prolifera-
tion, these mutations lead to replica-
tion stress, DNA damage, and a DNA 
damage response. The DNA damage 
response is a network of pathways that 
rapidly modulates many aspects of cel-
lular metabolism, particularly following 
the induction of cytotoxic lesions such 308 Cell 140, February 5, 2010 ©2010 Elsevias DNA double-strand breaks. A central 
part of the DNA damage response is the 
activation of p53, which results in cell-
cycle arrest, apoptosis, or senescence. 
These responses are important barriers 
to tumor progression and malignancy. 
Indeed, p53’s tumor suppressor activity 
is believed to be attenuated in human 
tumor cells, either by inactivating muta-
tions in the TP53 gene encoding p53 or er Inc.by altered expression of p53 modula-
tors and effectors. In unstressed cells, 
p53 is kept at low levels through its 
continuous degradation via the ubiq-
uitin-proteasome pathway, whereas 
upon DNA damage p53 degradation is 
attenuated (Figure 1). The primary regu-
lator of DNA damage-induced p53 sta-
bilization is the nuclear protein kinase 
ATM (ataxia-telangiectasia mutated), 
figure 1. Regulation of p53 by UsP10
(Left) In unstressed cells, the tumor suppressor protein p53 is kept at low levels in both the cytoplasm and the nucleus by the concerted action of the ubiquitin 
ligases Mdm2, Mdmx, and COP1. In addition, p53, Mdm2, and Mdmx are maintained at steady-state levels by the deubiquitinating enzyme USP7.
(Right) Following DNA damage, Mdm2 and Mdmx are phosphorylated by ATM and are downregulated as they can no longer interact with USP7. Phosphorylated 
COP1 is autodegraded outside the nucleus, and the deubiquitinating enzyme USP10 accumulates in the nucleus where it assists USP7 in the deubiquitina-
tion of p53, leading to its stabilization. USP10 can act as a tumor suppressor and an oncoprotein because it stabilizes both wild-type p53 and mutant p53, 
respectively (Yuan et al., 2010).which is activated following the induc-
tion of DNA double-strand breaks. ATM 
phosphorylates a multitude of proteins, 
including p53 and its negative regula-
tors: the ubiquitin ligases Mdm2 and 
COP1 that drive p53 ubiquitination and 
its strong inhibitor, Mdmx (Dornan et al., 
2006; Meulmeester et al., 2005). Phos-
phorylation of these proteins by ATM 
accelerates their proteasome-mediated 
degradation, thereby stabilizing p53. 
The phosphorylation of Mdm2 and 
Mdmx enhances their degradation by 
reducing their interaction with the deu-
biquitinating protease USP7/HAUSP in 
the nucleus. USP7 regulates p53 in a 
dual fashion: it stabilizes p53 directly by 
deubiquitinating it and simultaneously 
deubiquitinates and stabilizes Mdm2 
and Mdmx, thereby helping to keep the 
amount of p53 in check (Kruse and Gu, 
2009; Meulmeester et al., 2005).
In this issue of Cell, Yuan et al. (2010) 
show that the current picture of p53 acti-
vation and stabilization by ATM is incom-
plete, and they add another player to the 
loop, a deubiquitinating enzyme called 
USP10. USP10 turns out to directly deu-
biquitinate p53 and to be an essential 
regulator of the stability of this tumor 
suppressor protein. In unstressed cells, 
USP10 is localized mainly in the cyto-
plasm where it deubiquitinates p53, 
enabling re-entry of p53 into the nucleus 
(Figure 1, left panel). Indeed, reducing 
the amount of USP10 results in increased p53 degradation. Upon DNA damage 
and ATM activation, USP10 is phospho-
rylated and accumulates in the nucleus, 
where it joins forces with USP7 to stabi-
lize p53 via p53 deubiquitination (Figure 
1, right panel). Indeed, USP10 deple-
tion attenuates DNA damage-induced 
stabilization of p53, an effect that was 
rescued by overexpression of wild-type 
USP10 but not by mutant USP10 lack-
ing ATM phosphorylation sites. It will be 
interesting to discover whether overex-
pression of USP7 could also rescue the 
diminished DNA damage-induced p53 
response caused by USP10 depletion. 
This could address questions about the 
specificity of these two p53-deubiquit-
inating enzymes and reveal whether the 
combined action of USP7 and USP10 is 
required to determine p53 stability.
In view of the critical role of p53’s 
tumor suppressor activity in preventing 
tumor formation, each of its regulators 
can be thought of as either an oncopro-
tein or a tumor suppressor, depending 
on its effect on p53. Indeed, Yuan and 
colleagues find that USP10 levels are 
altered in renal cell carcinomas and cell 
lines derived from them. Most renal cell 
carcinomas do not contain mutant p53, 
and their USP10 levels are greatly dimin-
ished. However, a subset of renal cell 
carcinomas that do contain p53 muta-
tions have elevated USP10 levels and 
increased levels of mutant p53. Yuan 
and coworkers go on to show that in Cell 140such cases the high levels of mutant p53 
exert an oncogenic effect on the cultured 
tumor cells. USP10 thus appears to be 
a Janus-like player in tumorigenesis—it 
stabilizes both wild-type and mutant p53 
and so functions as both a tumor sup-
pressor and an oncoprotein.
The new findings point to USP10 as 
a potential therapeutic target for the 
roughly 50% of human cancers that 
contain p53 mutations. However, further 
work is needed to address the general-
ity of the correlation between USP10 and 
p53 levels. USP10 overexpression has 
been associated with poor prognosis in 
patients with glioblastoma multiforme, 
which could fit with Yuan et al.’s data 
on the enhancement of the malignant 
phenotype by high levels of mutant p53. 
Notably, in the renal cell carcinoma sam-
ples investigated by Yuan et al., the sta-
tus of wild-type p53 does not correlate 
with an increase in Mdm2 and Mdmx, as 
has been reported in other tumor types, 
like retinoblastoma. It would be of inter-
est to examine the expression of USP10 
in tumors with wild-type p53 and high 
Mdm2/Mdmx levels. It will also be impor-
tant to discover whether USP10 activity 
is involved in regulating the ubiquitina-
tion status of the mitochondrial fraction 
of p53, as has been reported for USP7; 
the deubiquitination of p53 by mito-
chondrial USP7 generates apoptotically 
active nonubiquitinated p53 (Marchenko 
et al., 2007)., February 5, 2010 ©2010 Elsevier Inc. 309
Both the yeast ortholog of USP10, 
Ubp3, and human USP10 have been 
implicated in vesicular transport and traf-
ficking of membrane proteins (Bomberger 
et al., 2009; Cohen et al., 2003). In yeast, 
the deubiquitination of Ubp3 target pro-
teins involved in this process depends on 
association of Ubp3 with another protein, 
Bre5 (Cohen et al., 2003). Interestingly, 
human USP10 interacts with the human 
Bre5 ortholog, G3BP1. However, this 
association may block the deubiquitinase 
activity of USP10. Notably, G3BP proteins 
interact with p53 and stimulate its local-
ization in the cytoplasm (Kim et al., 2007). 
It would be interesting to know whether 
regulation of p53 by USP10 is modu-
lated by G3BP proteins, as the expres-
sion of G3BP proteins is modulated in 
various tumors. Intriguingly, mutant p53 310 Cell 140, February 5, 2010 ©2010 Elsev
Males of all mammalian species store 
sperm in the caudal portion of the duc-
tus epididymis. These sperm have com-
pleted morphological differentiation and 
are generally believed to have termi-
nated gene expression, and yet they are 
not capable of fertilization. The capac-
ity to fertilize eggs is only expressed 
after sperm have been “educated” by 
the female reproductive tract. This final 
phase of maturation is known as capaci-
tation and results in the development of 
new patterns of flagellar motility, in the 
expression of chemotactic responsive-
ness, and in the acquisition of the ability 
to interact with eggs. An understand-
ing of capacitation is central to assisted 
reproductive approaches for treating 
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The acquisition of fertilization c
transport pathways that regulate
Hv1, the voltage-sensitive proton
of the functional maturation of scan stimulate the invasive capabilities of 
cancer cells by enhancing the endocytic 
recycling of membrane proteins such as 
epidermal growth factor receptor EGFR 
and α5β1 integrin (Muller et al., 2009). 
USP10 is important for endocytic traffick-
ing (Bomberger et al., 2009) and also, as 
Yuan et al. report, for stabilizing mutant 
p53. Future work will reveal whether this 
versatile deubiquitinase has even more 
talents up its sleeve.
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infertility, to the design of contracep-
tive agents, to our models of fertilization, 
and to deciphering the evolutionary pro-
cesses of sperm competition and sexual 
selection (Florman and Ducibella, 2006; 
Sutton et al., 2008). In this issue of Cell, 
Lishko et al. (2010), with their identifica-
tion of a voltage-gated proton channel 
(Hv1) in sperm, suggest an exciting new 
model that may account for the regula-
tion of sperm intracellular pH (pHi) and 
for key events that control the onset of 
capacitation.
One factor that regulates capacitation 
is the intracellular pH of sperm. The pHi 
is maintained at a slightly acidic level 
during sperm storage within the cauda 
epididymis and rises during capacitation. 
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Lou, Z. (2010). Cell, this issue.Both the acid load during sperm storage 
and the subsequent alkaline shift after 
release are required for fertility (Florman 
and Ducibella, 2006; Blomqvist et al., 
2006). Yet, the metabolic and ion trans-
port activities that control the pHi set 
point in sperm and modulate the capac-
itation-associated changes required for 
fertility are poorly understood.
Lishko et al. (2010) now show that a 
voltage-sensitive proton channel, Hv1, 
is present in human sperm. Hv1 con-
tains the voltage sensor domain that was 
first identified in voltage-sensitive cation 
channels, but it lacks the ion permeation 
pore of those channels. Instead, voltage-
driven conformational movements in the 
sensor activate an intrinsic transmem-
tility
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